Collagen can selectively trigger a platelet secretory phenotype via glycoprotein VI

PLoS One. 2014 Aug 12;9(8):e104712. doi: 10.1371/journal.pone.0104712. eCollection 2014.

Abstract

Platelets are not only central actors of hemostasis and thrombosis but also of other processes including inflammation, angiogenesis, and tissue regeneration. Accumulating evidence indicates that these "non classical" functions of platelets do not necessarily rely on their well-known ability to form thrombi upon activation. This suggests the existence of non-thrombotic alternative states of platelets activation. We investigated this possibility through dose-response analysis of thrombin- and collagen-induced changes in platelet phenotype, with regards to morphological and functional markers of platelet activation including shape change, aggregation, P-selectin and phosphatidylserine surface expression, integrin activation, and release of soluble factors. We show that collagen at low dose (0.25 µg/mL) selectively triggers a platelet secretory phenotype characterized by the release of dense- and alpha granule-derived soluble factors without causing any of the other major platelet changes that usually accompany thrombus formation. Using a blocking antibody to glycoprotein VI (GPVI), we further show that this response is mediated by GPVI. Taken together, our results show that platelet activation goes beyond the mechanisms leading to platelet aggregation and also includes alternative platelet phenotypes that might contribute to their thrombus-independent functions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / immunology
  • Blood Coagulation / physiology
  • Blood Platelets / metabolism*
  • Calcium Signaling
  • Collagen / metabolism*
  • Humans
  • Integrins / metabolism
  • P-Selectin / biosynthesis
  • Phosphatidylserines / biosynthesis
  • Platelet Activation / physiology*
  • Platelet Adhesiveness / physiology
  • Platelet Aggregation / physiology
  • Platelet Membrane Glycoproteins / antagonists & inhibitors
  • Platelet Membrane Glycoproteins / immunology*
  • Platelet Membrane Glycoproteins / metabolism
  • Thrombin / metabolism*
  • Thrombosis / pathology

Substances

  • Antibodies
  • Integrins
  • P-Selectin
  • Phosphatidylserines
  • Platelet Membrane Glycoproteins
  • platelet membrane glycoprotein VI
  • Collagen
  • Thrombin

Grants and funding

This work was supported by the Institut National de la Santé et de la Recherche Médicale and by grants from DHU FIRE, la Fondation de France, and CORDDIM Région Ile de France to Benoît Ho-Tin-Noé. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.